Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2012
02/15/2012CN102349983A Traditional Chinese medicine composition for treating ischemic apoplexia
02/15/2012CN102349966A Medicament for treating cerebral arteriosclerosis, cerebral blood circulation insufficiency and cerebral apoplexy sequela and preparation method thereof
02/15/2012CN102349955A External Chinese medicinal herb for treating hemorrhoid
02/15/2012CN102349951A Preparation method of hawthorn leaf extract
02/15/2012CN102349944A Nasal thermosensitive in-situ gel prepared by radix scutellariae extract, its preparation method and its application
02/15/2012CN102349940A Process for preparing thermopsis lanceolate total alkaloids and several high-purity medicinal substances
02/15/2012CN102349937A Preparation method of ixeris sonchifolia hance extractive
02/15/2012CN102349936A PNS (Panax Notoginseng Saponins) freeze-dried powder and preparation method thereof
02/15/2012CN102349935A Purpose of ginkgolic acid in preparing external preparation for treating venereal disease, gynopathy and perianal disease
02/15/2012CN102349931A Cockroach extract, preparation method thereof, and application of cockroach extract preparation in treatment of cardiovascular disease
02/15/2012CN102349923A Use of L-carnitine and glucose for the treatment of cardiovascular diesases
02/15/2012CN102349921A Brand new drug composition and preparation method thereof
02/15/2012CN102349911A New application of Youtibi and derivatives of Youtibi
02/15/2012CN102349904A Novel oral solid medicinal composition and its preparation method
02/15/2012CN102349903A New pharmaceutical composition containing levoamlodipine and valsartan and preparation method thereof
02/15/2012CN102349902A Brand new drug composition containing levamlodipine besylate and candesartan cilexetil and preparation method thereof
02/15/2012CN102349898A Application of sophocarpine to preparation of medicament for treating cardiovascular diseases caused by coxsackie virus B
02/15/2012CN102349893A Edaravone pharmaceutical composition
02/15/2012CN102349891A Pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection
02/15/2012CN102349889A Composition containing dronedarone
02/15/2012CN102349882A Medicinal composition containing trandolapril and preparation process thereof
02/15/2012CN102349880A Isradipine controlled-release tablets and preparation method thereof
02/15/2012CN102349869A Transdermal controlled release preparation of carvedilol
02/15/2012CN102133188B 一种西洛他唑脂质体固体制剂 One kind of cilostazol solid preparation of liposomes
02/15/2012CN102091212B 一种治疗复发性中心性浆液性脉络膜视网膜病的中药汤剂 A treatment for recurrent central serous retinopathy decoction
02/15/2012CN101966149B 一种脑梗塞治疗药物脂肪乳剂的制备 A process for preparing a fat emulsion infarction drug treatment
02/15/2012CN101953832B β-环糊精包合依达拉奉的口服药物组合物及其制备方法 β- cyclodextrin inclusion edaravone oral pharmaceutical composition and its preparation method
02/15/2012CN101912530B 一种超声提取银线草总黄酮的方法 A method of ultrasonic extraction of total flavonoids silver wire grass
02/15/2012CN101897682B 一种伊伐布雷定或其可药用盐固体制剂及其制备方法 One kind of ivabradine or a pharmaceutically acceptable salt solid preparation and its preparation method
02/15/2012CN101843889B 一种治疗淋巴水肿和静脉水肿的药物及其应用 A lymphedema and venous edema drug therapy and its application
02/15/2012CN101716269B 一种治疗原发性高血压病的中药组合物 A method for treating essential hypertension medicine composition
02/15/2012CN101530389B 人参皂苷Rg3磷脂复合物及其制备方法 Ginsenoside Rg3 phospholipid complex and its preparation method
02/15/2012CN101440343B 苦瓜保健酒及其配制方法 Bitter health wine and its preparation method
02/15/2012CN101375952B 一种用于治疗心脑血管疾病的中药组合物 A method for the treatment of cardiovascular and cerebrovascular disease, Chinese medicine composition
02/15/2012CN101310751B 一种具有益气养血作用的药物组合物的检测方法 BNI detection method has the effect of a pharmaceutical composition
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114970 Synthetic heparin monosaccharides
02/14/2012US8114966 Peptide-based passive immunization therapy for treatment of atherosclerosis
02/14/2012US8114900 Amorphous carvedilol dihydrogen phosphate
02/14/2012US8114885 Chemical compounds
02/14/2012US8114866 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme
02/14/2012US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
02/14/2012US8114400 Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/14/2012CA2402160C Heparinase iii and uses thereof
02/09/2012WO2012019076A1 Compositions and methods for preventing and treating cardiac ischemia/reperfusion injury
02/09/2012WO2012018791A2 Preparation of prasugrel hydrochloride
02/09/2012WO2012018790A2 Dual variable domain immunoglobulins and uses thereof
02/09/2012WO2012017663A1 Mononuclear cell separation column, mononuclear cell separation system, method for separating out mononuclear cells, mononuclear cells, and drug for internal administration
02/09/2012WO2012017551A1 Therapeutic agent for disease
02/09/2012WO2012017451A1 A bio-stabilized resveratrol formulation
02/09/2012WO2012017166A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/09/2012WO2012017105A1 Microrna that can be used for treating arrhythmogenic channelopathies
02/09/2012WO2012016969A1 Highly crystalline valsartan
02/09/2012WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/09/2012WO2012016549A1 Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease
02/09/2012WO2012006320A8 Photosensitive cardiac rhythm modulation systems
02/09/2012WO2011062906A8 Treatment of atrial fibrillation
02/09/2012US20120035274 Composition for Prevention or Treatment of Obesity, Dyslipidemia, Fatty Liver or Insulin Resistance Syndrome Comprising Camphene as Active Ingredients
02/09/2012US20120035268 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
02/09/2012US20120035265 Compositions, methods, and devices for the treatment of dysmenorrhea
02/09/2012US20120035262 Compositions and methods for lowering triglycerides
02/09/2012US20120035259 Controlled Release of Nitric Oxide And Drugs From Functionalized Macromers And Oligomers
02/09/2012US20120035256 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
02/09/2012US20120035243 Dual targeting of mir-208 and mir-499 in the treatment of cardiac disorders
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035226 Oxadiazole derivatives
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035215 Method of predicting a predisposition to qt prolongation
02/09/2012US20120035214 Renin inhibitors
02/09/2012US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use
02/09/2012US20120035199 Spiroheterocyclic compounds and their uses as therapeutic agents
02/09/2012US20120035194 Substituted 2-amino-fused heterocyclic compounds
02/09/2012US20120035191 Deuterium-enriched pyrimidine compounds and derivatives
02/09/2012US20120035172 Purinone Derivatives as HM74A Agonists
02/09/2012US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035159 Substituted isoquinoline derivative
02/09/2012US20120035158 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
02/09/2012US20120035155 Indole-2-carboxamide deivative
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035151 Substituted dihydropyrazolones and their use
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120035149 Prokineticin Receptor Antagonists And Uses Thereof
02/09/2012US20120035141 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
02/09/2012US20120035140 Carbamoylphosphonates as inhibitors and uses thereof
02/09/2012US20120035131 Pyrazoline compounds
02/09/2012US20120035127 Process for the production of a composition, the composition and the use thereof as food additive
02/09/2012US20120035111 Therapeutic Application of Adiponectin in Patients with Acute Myocardial Infarction
02/09/2012US20120035107 Compositions for achieving a therapeutic effect in an anatomical structure
02/09/2012US20120035099 Fgf21 analogues and derivatives
02/09/2012US20120035096 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
02/09/2012US20120035095 Orally administered peptides synergize statin activity
02/09/2012US20120035094 F11 receptor (f11r) antagonists as therapeutic agents
02/09/2012US20120034326 Novel herbal formulation advocated for the prevention and management of coronary heart disease
02/09/2012US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
02/09/2012US20120034308 Reduced-cholesterol dairy product for use as a medicament
02/09/2012US20120034277 Resuscitation fluid
02/09/2012US20120034272 Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic
02/09/2012US20120034270 S1P Receptors Modulators
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 1595